Nuclear
Medicine
Molecular imaging and targeted radionuclide therapy — one of the first comprehensive nuclear medicine centres in South Tamil Nadu.
Overview
The Nuclear Medicine Department provides advanced diagnostic imaging and targeted radionuclide therapy. Nuclear medicine uses small amounts of safe radioactive tracers to evaluate organ function and detect disease at a molecular level — often before structural changes appear on conventional imaging.
Radionuclide scans are performed using a gamma camera, while advanced PET-CT combines functional and anatomical imaging for precise diagnosis, treatment planning and response assessment.
Dr. V M Pradeep
Leads a comprehensive nuclear medicine programme covering PET-CT, SPECT, conventional gamma camera imaging and targeted radionuclide therapies including Lutetium-177 PSMA and DOTA-TATE — providing precision oncology services within the region.
Equipment & Technology
A state-of-the-art platform supporting both functional imaging and therapeutic procedures.
Functional + anatomical imaging for staging and treatment response.
3D imaging for organ function and disease evaluation.
Dedicated inpatient facilities for high-dose I-131 and Lutetium-177 therapies.
Nuclear Scans (Gamma Camera & SPECT)
Radionuclide imaging for early detection, accurate diagnosis and treatment guidance across multiple organ systems.
Bone metastasis, infections and other bone disorders.
Kidney structure, cortical function and renal scarring.
Kidney function, drainage and urinary obstruction.
Evaluation of thyroid nodules and function.
Follow-up and evaluation of thyroid cancer.
Neuroendocrine tumors — neuroblastoma, pheochromocytoma.
Localisation of parathyroid adenomas.
Evaluation of liver and gallbladder function.
Assessment of gastric motility disorders.
Pulmonary blood flow and lung function.
Assessment of myocardial blood flow.
PET-CT Imaging
Combining functional PET with anatomical CT for highly precise information about the location and extent of disease.
Cancer detection, staging and treatment monitoring.
FAPI PET imaging for a broad range of solid tumors.
Imaging of neuroendocrine tumors.
Therapeutic Nuclear Medicine
Targeted radionuclide therapies that deliver radiation directly to cancer cells while minimising exposure to surrounding normal tissue.
Targeted therapy for advanced prostate cancer.
Targeted therapy for neuroendocrine tumors.
Palliation of painful bone metastases.
Thyroid cancer and hyperthyroidism therapy.
Therapy for high-risk neuroblastoma.
Lutetium-177 targeted radionuclide therapy using DOTA and PSMA ligands is routinely performed for neuroendocrine tumors and advanced prostate cancer — bringing highly specialised precision oncology to South Tamil Nadu.